Abstract
Objectives: KLHL6 is a recently described BTB-Kelch protein with selective expression in lymphoid tissues and is most strongly expressed in germinal center B cells. Methods: Using gene expression profiling as well as immunohistochemistry with an anti-KLHL6 monoclonal antibody, we have characterized the expression of this molecule in normal and neoplastic tissues. Protein expression was evaluated in 1,058 hematopoietic neoplasms. Results: Consistent with its discovery as a germinal center marker, KLHL6 was positive mainly in B-cell neoplasms of germinal center derivation, including 95% of follicular lymphomas (106/112). B-cell lymphomas of non-germinal center derivation were generally negative (0/33 chronic lymphocytic leukemias/small lymphocytic lymphomas, 3/49 marginal zone lymphomas, and 2/66 mantle cell lymphomas). Conclusions: In addition to other germinal center markers, including BCL6, CD10, HGAL, and LMO2, KLHL6 immunohistochemistry may prove a useful adjunct in the diagnosis and future classification of B-cell lymphomas.
Original language | English (US) |
---|---|
Pages (from-to) | 465-476 |
Number of pages | 12 |
Journal | American journal of clinical pathology |
Volume | 148 |
Issue number | 6 |
DOIs | |
State | Published - Dec 1 2017 |
Externally published | Yes |
Keywords
- Hematopathology
- Immunohistochemistry
- KLHL6
- Lymphoma
ASJC Scopus subject areas
- Pathology and Forensic Medicine